Grants and Contributions:

Back to search

Title:

Pharmacy SaaS Product - Document Conversion to AI Enabled

Agreement Number:

1026750

Agreement Value:

$75,000.00

Agreement Date:

Feb 1, 2025 - May 31, 2025

Description:

Medi-scribe seeks to integrate AI into its workflow automation software for prescribing, medication reviews, renewals, medication adaptations, and other pharmacy functions. This AI integration will give Medi-scribe more flexibility, options, accuracy, and performance, to help the company scale its solution to meet growing demand across Canada and the U.S. The pilot project will develop an AI agent that customizes user documentation across clinical workflows, reducing administrative burden, improving communication, and enhancing patient care. The project will span 5 months, and be executed by two developers, one product designer, and one product manager to support the development, integration, and testing of the AI solution.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Calgary, Alberta, CA T2K 4J5

Reference Number:

172-2024-2025-Q4-1026750

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

776581803

Recipient Type:

For-profit organization

Recipient's Operating Name:

Medi-scribe

Recipient's Legal Name:

MediScribe Solutions Inc.

Federal Riding Name:

Calgary Nose Hill

Federal Riding Number:

48009

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

51121